New combo aims to cut transfusions for blood disorder patients
Disease control
Recruiting now
This Phase 2 trial tests whether adding low-dose thalidomide to luspatercept can reduce the number of blood transfusions needed by adults with transfusion-dependent β-thalassemia. 78 participants will be randomly assigned to receive either the combination or luspatercept alone fo…
Phase: PHASE2 • Sponsor: Rongrong Liu • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC